Transgene S.A. Aktie
1,26 €
Deine Einschätzung
Transgene S.A. Aktie
Was spricht für und gegen Transgene S.A. in den nächsten Jahren?
Pro
Kontra
Rendite von Transgene S.A. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Transgene S.A. | -4,12 % | -10,53 % | 15,63 % | -29,80 % | -6,12 % | -49,38 % | -56,47 % |
Valneva SE | 0,80 % | -2,72 % | -4,13 % | -18,06 % | -26,44 % | -69,55 % | 3,79 % |
Nanobiotix | -3,45 % | 4,11 % | -4,57 % | 157,87 % | -17,06 % | -59,90 % | -53,53 % |
Quantum Genomics S.A. | 16,12 % | 12,40 % | 21,38 % | -6,95 % | 27,73 % | -97,12 % | - |
Kommentare
News
Transgene Announces Upcoming Investor Meetings
Regulatory News:
TRANSGENE (Paris:TNG) today announces that Management will participate in several investor events in the upcoming investor events, as set out below.
Transgene will meet
Transgene Strengthens its Leadership Team to Accelerate its Growth Strategy
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the
Transgene Reports Business Update and Q3 2023 Financial Position
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update and its